COMBINED LDL-C AND LIPOPROTEIN (A) LEVELS IN PREDICTION OF RESIDUAL ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK: THE AIM-HIGH TRIAL (ATHEROTHROMBOSIS INTERVENTION IN METABOLIC SYNDROME WITH LOW HDL/HIGH TRIGLYCERIDES: IMPACT ON GLOBAL HEALTH OUTCOMES)
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(17)35109-4
Abstract: Background: In patients with atherosclerotic cardiovascular disease (ASCVD), the relationship of lipoprotein(a) [Lp(a)] levels with ASCVD outcomes when LDL-C levels are controlled remains unclear. Methods: We studied 3,196 patients with ASCVD in the AIM-HIGH trial,… read more here.
Keywords: atherosclerotic cardiovascular; aim high; lipoprotein levels; cardiovascular disease ... See more keywords